molecules of the month

January 2022

The January 2022 edition of Drug Hunter’s Small Molecules of the Month includes a reversible CoV-2 main protease inhibitor from Shionogi in Ph. II/III which doesn’t require a PK booster like ritonavir, a recently disclosed oral, once-daily Factor XIa inhibitor, and the first-in-class STING agonist that was once Aduro’s lead.

Thanks to reviewers for their feedback this month.

Premium Members can save time gathering the key details behind each molecule with dedicated summaries and the Member’s slide deck. Alternatively, sign up for the free e-mail newsletter to get free previews of member content.

A slide deck with more details about each molecule is available.

Upgrade Membership to Download Slide Deck

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

Newsletter

nominate a molecule

Encountered an interesting new molecule? Let your community know!

become a reviewer

Get sneak previews of upcoming molecules and share your knowledge and expertise with the drug discovery community.

past molecules of the month

Check out previous selections below.

molecules of the year nominees

Previous selections for Drug Hunter’s Molecule of the Year below.

hall of fame
molecules of the year

Previous selections for Drug Hunter’s Molecule of the Year below.

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

Newsletter

Join Subscribers from